We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expert Committee Finds Akcea’s NDA for Rare Genetic Disease is Safe and Effective
Expert Committee Finds Akcea’s NDA for Rare Genetic Disease is Safe and Effective
An FDA advisory committee voted 12 to 8 Thursday that Akcea Therapeutics’ NDA for treatment of a rare genetic disease demonstrated safety and efficacy.